CD8A and Carcinoma, Lewis Lung: Previously, we demonstrated an increased cytotoxicity and feasibility of using reprogrammed murine CD3+CD8+ T-lymphocytes to eliminate CSCs in Lewis lung carcinoma in mice [41].